Not available
Quote | Celgene Corporation (NASDAQ:CELG)
Last: | $ |
---|---|
Change Percent: | 0.88% |
Open: | $101.11 |
Close: | $101.86 |
High: | $102.02 |
Low: | $101.11 |
Volume: | 2,053,419 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Celgene Corporation (NASDAQ:CELG)
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
Bristol Myers Squibb has an impressive portfolio of assets and strong financials. The company has recently wrapped up large acquisitions. The company is focused on redeveloping its portfolio and expects a massive increase in revenue from new businesses. Going forward, we expect sh...
Message Board Posts | Celgene Corporation (NASDAQ:CELG)
Subject | By | Source | When |
---|---|---|---|
Better Buy: Celgene vs. Gilead Sciences | BottomBounce | investorshub | 10/24/2020 12:38:18 PM |
Sorry, dont know | patrickjishere | investorshub | 02/18/2019 10:31:14 PM |
Do you or anyone here know the tax | rosemountbomber | investorshub | 02/18/2019 10:08:04 PM |
Advances in Cancer Drugs Fuel Deal -- WSJ | TheFinalCD | investorshub | 01/04/2019 2:09:31 PM |
Yep, I like $BMY and the deal. | patrickjishere | investorshub | 01/03/2019 7:24:29 PM |
News, Short Squeeze, Breakout and More Instantly...
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...